IBM Jazz Reporting Service up to 5.0.2/6.0.5 Web UI cross site scripting
CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
---|---|---|
4.4 | $0-$5k | 0.00 |
A vulnerability classified as problematic was found in IBM Jazz Reporting Service up to 5.0.2/6.0.5 (Reporting Software). This vulnerability affects an unknown functionality of the component Web UI. The manipulation with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
IBM Jazz Reporting Service (JRS) 5.0 through 5.0.2 and 6.0 through 6.0.5 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 137448.
The bug was discovered 04/23/2018. The weakness was presented 04/25/2018 (Website). The advisory is available at exchange.xforce.ibmcloud.com. This vulnerability was named CVE-2018-1363 since 12/13/2017. The attack can be initiated remotely. The successful exploitation needs a single authentication. Successful exploitation requires user interaction by the victim. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 03/07/2023). It is expected to see the exploit prices for this product increasing in the near future.This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
The vulnerability was handled as a non-public zero-day exploit for at least 2 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 104014†). See VDB-117092 for similar entry.
Product
Type
Vendor
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB CVSS-B Score: 🔍VulDB CVSS-BT Score: 🔍
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
AV | AC | Au | C | I | A |
---|---|---|---|---|---|
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
---|---|---|---|---|---|
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
0-Day | unlock | unlock | unlock | unlock |
---|---|---|---|---|
Today | unlock | unlock | unlock | unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/13/2017 🔍04/23/2018 🔍
04/23/2018 🔍
04/25/2018 🔍
04/25/2018 🔍
04/26/2018 🔍
03/07/2023 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2018-1363 (🔍)
X-Force: 137448
SecurityFocus: 104014 - IBM Jazz Reporting Service CVE-2018-1363 Cross Site Scripting Vulnerability
See also: 🔍
Entry
Created: 04/26/2018 10:19 AMUpdated: 03/07/2023 05:30 PM
Changes: 04/26/2018 10:19 AM (62), 01/31/2020 05:21 PM (3), 03/07/2023 05:23 PM (3), 03/07/2023 05:30 PM (1)
Complete: 🔍
Cache ID: 44:3AA:40
No comments yet. Languages: en.
Please log in to comment.